Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tum...

Full description

Bibliographic Details
Main Authors: Amrit Bhusal, Suraj KC, Tek Nath Yogi, Rakesh Kumar Gupta, Abhijeet Kumar, Bhawani Khanal, Shailendra Katwal, Durga Neupane, Samikshya Lamichhane, Ranjan Bhagat
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Radiology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043323009597
Description
Summary:Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.
ISSN:1930-0433